Resident Evil Sales 2026 Reveal Capcom’s Hidden Strength

Resident Evil 4’s extraordinary quarterly growth and Onimusha’s comeback reveal why Capcom’s older franchises remain essential to its success.

Published on  

Resident Evil sales 2026 – Grace Ashcroft holds a pistol on a rainy Raccoon City street, surrounded by police cars and fog.

A blockbuster launch can dominate headlines for a few weeks. Keeping a game selling years later is a different achievement. The latest Resident Evil sales 2026 figures show Capcom succeeding at both, with Resident Evil Requiem reaching 8.5 million copies while the Resident Evil 4 remake delivers the company’s biggest quarterly increase. Meanwhile, Onimusha is making a surprisingly strong return.

Capcom’s updated Platinum Titles ranking, covering sales through September 30, 2026, reveals something more interesting than a collection of milestones. The publisher is generating fresh demand from games released years apart, while introducing new projects and reviving older franchises. That combination could be its greatest commercial advantage.

Resident Evil sales 2026 reveal an unexpected winner

Resident Evil Requiem has already sold 8.5 million units since launching in February 2026 on PS5, Xbox Series X|S, Nintendo Switch 2 and PC. Its total increased by 500,000 copies between June 30 and September 30, confirming that the latest mainline adventure continues attracting buyers beyond its initial release window.

However, Requiem was not Capcom’s fastest-growing title during the quarter. That distinction belongs to Resident Evil 4 remake, which added 1.1 million units and reached 17.1 million lifetime sales. Released in March 2023, the remake generated more than twice Requiem’s quarterly increase despite being considerably older.

That contrast is revealing. A new installment benefits from launch marketing, immediate attention and anticipation. An established remake must continue persuading audiences long after its debut. Capcom’s ability to accomplish both helps explain why its survival horror catalog remains so commercially valuable.

Why Resident Evil sales 2026 matter beyond Requiem

The rest of the franchise reinforces this pattern. Resident Evil 2 remake has reached 20.3 million copies, adding another 600,000 during the quarter. Resident Evil 7 stands at 18.8 million, Resident Evil Village at 16.2 million and Resident Evil 3 remake at 14.9 million. Each of those three games gained 400,000 units.

These figures show how differently individual Resident Evil adventures can coexist. Resident Evil 7 emphasizes first-person survival horror, Village develops that formula further, and the modern remakes reinterpret familiar stories through updated gameplay. Rather than depending on a single experience, Capcom offers several entry points into the same franchise.

This approach also gives additional significance to Capcom’s strategy for modernizing classic Resident Evil games. Remakes are not merely nostalgic releases. Their continued sales suggest they can remain relevant alongside entirely new installments, potentially introducing players to stories they originally missed.

Nevertheless, quarterly sales alone cannot explain why individual customers purchased these games. Discounts, platform availability and promotional activity may influence demand, but the figures do not isolate those factors. What they establish is that Resident Evil’s commercial life extends far beyond launch month.

Onimusha’s comeback offers Capcom another opportunity

Resident Evil may dominate the conversation, but another result deserves attention. Onimusha: Way of the Sword has sold 1.7 million copies following its September 2026 release. Available on PS5, Xbox Series X|S, Nintendo Switch 2 and PC, the new adventure has entered Capcom’s Platinum Titles ranking immediately.

Its position becomes more interesting when compared with earlier installments. Way of the Sword has already exceeded the 1.52 million lifetime sales recorded for Onimusha 3: Demon Siege. Furthermore, it is approaching Onimusha: Warlords at 2.02 million and Onimusha 2: Samurai’s Destiny at 2.1 million.

Those comparisons are not perfectly equivalent. The games launched in different periods, on different hardware and under different market conditions. Even so, the newcomer reaching 1.7 million so quickly provides a promising commercial starting point for a franchise that spent years away from major new releases.

There is an important distinction here. Resident Evil demonstrates how Capcom can maintain an established blockbuster series. Onimusha suggests the publisher may also have room to bring dormant properties back into the spotlight. Its early sales make a stronger case for the franchise’s future, although they do not confirm another installment.

Monster Hunter and other franchises complete the picture

Capcom’s broader portfolio provides useful context. Monster Hunter: World remains its best-selling individual game at 22.5 million units, rising to 30.8 million when Iceborne Master Edition is included. Monster Hunter Rise follows with 19.7 million, while Monster Hunter Wilds has reached 12.2 million after adding 400,000 during the latest quarter.

Wilds illustrates why launch success and long-term momentum should be evaluated separately. Its latest increase is respectable, but its performance remains an important topic as Capcom works to maintain player interest. Our earlier examination of the Monster Hunter Wilds comeback and its next commercial challenges explores that situation in greater detail.

Elsewhere, Devil May Cry 5 has climbed to 12.7 million copies, gaining 400,000, while Street Fighter 6 has reached 7.5 million after another 300,000 sales. Meanwhile, science-fiction adventure PRAGMATA stands at 2.7 million following its April 2026 debut, an increase of 200,000 during the quarter.

Another quieter milestone belongs to Mega Man Zero/ZX Legacy Collection, which has reached one million copies and entered the Platinum Titles ranking. Its inclusion demonstrates that even collections of older games can achieve meaningful lifetime sales without competing directly with Capcom’s largest contemporary productions.

What Capcom’s latest figures suggest about its future

Perhaps the clearest takeaway is that Capcom does not need every release to become its next Monster Hunter: World. Its business benefits from different types of success: new blockbusters, enduring remakes, established action franchises, experimental projects and revived classics.

Consider the contrast between Requiem and Onimusha. One strengthens a franchise already central to Capcom’s identity. The other tests whether a recognizable but less active property can find a substantial modern audience. Resident Evil 4 remake adds a third possibility: a game can continue generating impressive sales years after its original release.

That commercial foundation also provides context for future Resident Evil projects. Capcom has confirmed a Code Veronica remake for 2027, although its eventual performance remains unknown. Our coverage of the Resident Evil Veronica development discussion separates official plans from unconfirmed claims surrounding its schedule.

The numbers come from Capcom’s official Platinum Titles database, which the company updates quarterly and which includes digital sales. These are cumulative unit figures rather than revenue or profit rankings. Consequently, they cannot establish which individual release generated the highest earnings during the period.

Ultimately, Resident Evil sales 2026 tell a bigger story than Requiem’s impressive debut. Capcom has built a catalog where older games continue finding customers while new releases expand its reach. With Onimusha showing early promise, the next question is whether the publisher can turn another returning franchise into a lasting success. Which classic Capcom series deserves that opportunity next?

Share it so all your friends hear about it: